Assignee
CELL SIGNALING TECHNOLOGY INC
US·41 granted patents·55 pending applications·308 citations·filing 1998–2022
Top patents by PatentIndex Score
96 records- 0195US7700339B2Gene defects and mutant ALK kinase in human solid tumorsCELL SIGNALING TECHNOLOGY INC·Filed 2007·Granted Apr 20, 2010·22 cites·15 claims
- 0293US7198896B2Immunoaffinity isolation of modified peptides from complex mixturesCELL SIGNALING TECHNOLOGY INC·Filed 2002·Granted Apr 3, 2007·62 cites·37 claims
- 0391US7259022B2Production of motif-specific and context-independent antibodies using peptide libraries as antigensCELL SIGNALING TECHNOLOGY INC·Filed 2001·Granted Aug 21, 2007·26 cites·14 claims
- 0490US6982318B1Production of motif-specific and context-independent antibodies using peptide libraries as antigensCELL SIGNALING TECHNOLOGY INC·Filed 2000·Granted Jan 3, 2006·25 cites·11 claims
- 0590US6441140B1Production of motif-specific and context-independent antibodies using peptide libraries as antigensCELL SIGNALING TECHNOLOGY INC·Filed 1998·Granted Aug 27, 2002·76 cites·5 claims
- 0689US8383799B2Translocation and mutant ROS kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2008·Granted Feb 26, 2013·5 cites·5 claims
- 0789US8377642B2Gene defects and mutant ALK kinase in human solid tumorsCELL SIGNALING TECHNOLOGY INC·Filed 2010·Granted Feb 19, 2013·5 cites·36 claims
- 0888US10036756B2Mass spectrometry analysis of mutant polypeptides in biological samplesCELL SIGNALING TECHNOLOGY INC·Filed 2016·Granted Jul 31, 2018·3 cites·16 claims
- 0988US7344714B2Production of motif-specific and context-independent antibodies using peptide libraries as antigensCELL SIGNALING TECHNOLOGY INC·Filed 2002·Granted Mar 18, 2008·16 cites·4 claims
- 1086US7183385B2Phospho-specific antibodies to Flt3 and uses thereofCELL SIGNALING TECHNOLOGY INC·Filed 2003·Granted Feb 27, 2007·40 cites·15 claims
- 1185US10551383B2Methods of detecting a polypeptide having anaplastic lymphoma kinase activity in kidney cancerCELL SIGNALING TECHNOLOGY INC·Filed 2015·Granted Feb 4, 2020·2 cites·5 claims
- 1284US11377486B2Motif-specific and context-independent antibodies that specifically bind to a sumoylated lysine-containing residueCELL SIGNALING TECHNOLOGY INC·Filed 2019·Granted Jul 5, 2022·2 cites·6 claims
- 1382US10670606B2Mass spectrometry analysis of mutant polypeptides in biological samplesCELL SIGNALING TECHNOLOGY INC·Filed 2018·Granted Jun 2, 2020·1 cites·20 claims
- 1482US9523130B2Methods of treating non-small cell lung carcinoma (NSCLC)CELL SIGNALING TECHNOLOGY INC·Filed 2016·Granted Dec 20, 2016·1 cites·29 claims
- 1580US9988688B2Compositions for detecting mutant anaplastic lymphoma kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2015·Granted Jun 5, 2018·1 cites·15 claims
- 1678US9738711B2Production of motif-specific and context-independent antibodies using peptide libraries as antigensCELL SIGNALING TECHNOLOGY INC·Filed 2014·Granted Aug 22, 2017·2 cites·12 claims
- 1778US9181326B2Analysis of ubiquitinated polypeptidesCELL SIGNALING TECHNOLOGY INC·Filed 2013·Granted Nov 10, 2015·2 cites·7 claims
- 1877US12577295B2Motif-specific and context-independent antibodies that specifically bind to a sumoylated lysine-containing residueCELL SIGNALING TECHNOLOGY INC·Filed 2022·Granted Mar 17, 2026·0 cites·9 claims
- 1977US11505833B2Compositions for detecting mutant anaplastic lymphoma kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2020·Granted Nov 22, 2022·0 cites·10 claims
- 2076US7999080B2Reagents for the detection of protein phosphorylation in signaling pathwaysCELL SIGNALING TECHNOLOGY INC·Filed 2007·Granted Aug 16, 2011·6 cites·2 claims
- 2176US7833736B2Protein markers of responsiveness to type III receptor tyrosine kinase inhibitorsCELL SIGNALING TECHNOLOGY INC·Filed 2007·Granted Nov 16, 2010·5 cites·17 claims
- 2274US11761005B2Translocation and mutant ROS kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2020·Granted Sep 19, 2023·0 cites·10 claims
- 2374US9328349B2Translocation and mutant ROS kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2014·Granted May 3, 2016·1 cites·32 claims
- 2474US7807789B2Reagents for the detection of protein phosphorylation in EGFR-signaling pathwaysCELL SIGNALING TECHNOLOGY INC·Filed 2007·Granted Oct 5, 2010·1 cites·6 claims
- 2574US2022003771A1Methods of detecting a polypeptide having anaplastic lymphoma kinase activity in kidney cancerCELL SIGNALING TECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 2673US10870892B2Compositions for detecting mutant anaplastic lymphoma kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2018·Granted Dec 22, 2020·0 cites·12 claims
- 2773US2015184158A1Translocation and mutant ros kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2014·Application pending·0 cites
- 2872US7973134B2Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathwaysCELL SIGNALING TECHNOLOGY INC·Filed 2006·Granted Jul 5, 2011·1 cites·3 claims
- 2972US2020363417A1Methods of detecting a polypeptide having anaplastic lymphoma kinase activity in kidney cancerCELL SIGNALING TECHNOLOGY INC·Filed 2019·Application pending·0 cites
- 3071US11428696B2Mass spectrometry analysis of mutant polypeptides in biological samplesCELL SIGNALING TECHNOLOGY INC·Filed 2020·Granted Aug 30, 2022·0 cites·19 claims
- 3170US10955416B2Compositions for detecting mutant anaplastic lymphoma kinase in human lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2018·Granted Mar 23, 2021·0 cites·9 claims
- 3269US7932044B2Identification of non-small cell lung carcinoma (NSCLC) tumors expressing PDGFR-αCELL SIGNALING TECHNOLOGY INC·Filed 2005·Granted Apr 26, 2011·2 cites·13 claims
- 3369US2022267854A1Egfr and ros1 kinase in cancerCELL SIGNALING TECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 3468US2021349095A1Ros kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 3567US2018156802A1Methods of treating lung cancer by administration of an alk inhibitorCELL SIGNALING TECHNOLOGY INC·Filed 2017·Application pending·0 cites
- 3664US11352418B2Analysis of ubiquitinated polypeptidesCELL SIGNALING TECHNOLOGY INC·Filed 2019·Granted Jun 7, 2022·0 cites·8 claims
- 3764US11099188B2ROS kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2018·Granted Aug 24, 2021·0 cites·4 claims
- 3863US2020080159A1Translocation and mutant ros kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2019·Application pending·0 cites
- 3962US2021079445A1Multi Component DetectionCELL SIGNALING TECHNOLOGY INC·Filed 2020·Application pending·0 cites
- 4062US2014134640A1Gene Defects And Mutant ALK Kinase In Human Solid TumorsCELL SIGNALING TECHNOLOGY INC·Filed 2013·Application pending·0 cites
- 4162US2013071841A1Translocation and mutant ros kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2012·Application pending·0 cites
- 4261US2016091493A1Method for predicting the response to her2-directed therapyCELL SIGNALING TECHNOLOGY INC·Filed 2015·Application pending·0 cites
- 4360US10526661B2Translocation and mutant ROS kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2016·Granted Jan 7, 2020·0 cites·17 claims
- 4460US7977462B2Tyrosine phosphorylation sitesCELL SIGNALING TECHNOLOGY INC·Filed 2008·Granted Jul 12, 2011·1 cites·2 claims
- 4560US2016193208A1Identification of Non-Small Cell Lung Carcinoma (NSCLC) Tumors Expressing PDGFR-alphaCELL SIGNALING TECHNOLOGY INC·Filed 2015·Application pending·0 cites
- 4660US2003068652A1Positive identification of phospho-proteins using motif-specific, context-independent antibodies coupled with database searchingCELL SIGNALING TECHNOLOGY INC·Filed 2002·Application pending·0 cites
- 4759US9539254B2Mutant ROS expression in human cancerCELL SIGNALING TECHNOLOGY INC·Filed 2014·Granted Jan 10, 2017·0 cites·8 claims
- 4859US2013266965A1Identification of Non-Small Cell Lung Carcinoma (NSCLC) Tumors Expressing PDGFR-ALPHACELL SIGNALING TECHNOLOGY INC·Filed 2013·Application pending·0 cites
- 4959US2011045534A1Nucleic Acid Cassette For Producing Recombinant AntibodiesCELL SIGNALING TECHNOLOGY INC·Filed 2009·Application pending·0 cites
- 5059US2010216718A1Cancer Classification and Methods of UseCELL SIGNALING TECHNOLOGY INC·Filed 2008·Application pending·0 cites
Showing the top 50 of 96 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →